Health Bulletin 12/ October/ 2021

Published On 2021-10-12 13:30 GMT   |   Update On 2021-10-19 12:02 GMT
Advertisement

Here are the top Health Stories of the day

SC assures 'mechanism' for grievances redressal of overcharging by hospitals, doctors

The Supreme Court on Friday said that it will devise a mechanism for redressal of grievances concerning overcharging of expenses by hospitals and doctors from Covid-19 patients during the second wave of the pandemic.

A bench of Justices DY Chandrachud and BV Nagarathna while issuing notice to the Centre said, "We will devise a mechanism to deal with such grievances".

Advertisement

For more details, check out the full story on the link below:


Raid on Hetero Pharma Group: IT Dept detects Rs 550 crore hidden income, seizes Rs 142 crore cash

The Income Tax Department detected "unaccounted" income of Rs 550 crore and seized over Rs 142 crore cash after it recently raided Hyderabad-based Hetero pharmaceutical group, official sources claimed on Saturday.

Company officials were not immediately available for comment.

For more details, check out the full story on the link below:

Raid On Hetero Pharma Group: IT Dept Detects Rs 550 Crore Hidden Income, Seizes Rs 142 Crore Cash


Maharashtra govt rewards resident doctors with Rs 1.21 lakh each for their services in covid 19 pandemic

Acknowledging the services of resident doctors amid the COVID-19 pandemic, the Maharashtra Government has recently issued a resolution announcing to give Rs 1.21 lakh to each of the resident doctors working in government, civic as well as government Ayurveda colleges.

However, the government resolution has excluded the graduating batch of residents from this reward. Despite working in the COVID wards for more than one year, the doctors after being excluded from this, are feeling short-changed, adds TOI.

For more details, check out the full story on the link below:

Advisory by ayush ministry for refrain from use of Ashwagandha

The Ministry of AYUSH has recently directed Ayurveda, Siddha and Unani (ASU) drug manufacturers to refrain from use of Aswagandha (Withania somnifera) leaves, holding that no substantial evidence and literature is available to endorse the efficacy of crude drug or extract of Aswagandha.

In this regard, the Ministry has issued an advisory to All ASU Drugs Manufacturers Associations seeking the manufacturers of the crude drug/extracts, sellers, ASU drug manufacturing companies, ASU drug exporters not to use Withania somnjfera leaves either in crude or extract or any other form for therapeutic purposes under the ambit of ASU drugs as per textual indications or as a food supplements in the name of ASU drugs.

For more details, check out the full story on the link below:


DCI Issues Measures for Curbing Menace of Ragging in Institutions

Aiming to ensure that no incident of ragging takes place in the dental institutions across the Country, the Dental Council of India (DCI) has recently written to the Heads of all the Dental colleges in India to strictly implement the measures for curbing the menace of ragging in their institutes.

Further, in the letter dated October 7, 2021, the Assistant Secretary of DCI, Vinay Gupta has reminded the Principals of the Dental colleges that "as per DCI Regulations on Curbing the Menace of Ragging in Dental Colleges, 2009, it is the responsibility of all the institution to ensure that no incident of ragging takes place in their dental institution and measures taken to curb it may be reviewed."

For more details, check out the full story on the link below:

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News